Zelicapavir is an orally active inhibitor of respiratory syncytial virus (RSV) specifically targeting the viral replication process. With an effective concentration (EC50) of less than 0.4 μM, it demonstrates potent antiviral activity. This compound is applicable in research focused on understanding RSV pathogenesis and developing therapeutic strategies against RSV infections.
Zelicapavir is an orally active inhibitor of respiratory syncytial virus (RSV) specifically targeting the viral replication process. With an effective concentration (EC50) of less than 0.4 μM, it demonstrates potent antiviral activity. This compound is applicable in research focused on understanding RSV pathogenesis and developing therapeutic strategies against RSV infections.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
